SciTech Second Quarterly 2025 Newsletter

SciTech Second Quarterly 2025 Newsletter NEWS PROVIDED BY SciTech Development 11 Jun, 2025, 09:00 ET DETROIT, Jun. 11, 2025 — Read the latest Second Quarterly 2025 newsletter here.  This captures all the updates including strong early data in T-cell lymphoma, FDA approval on our second IND for small cell lung cancer trial, expanded manufacturing, $20M Series A launch,…

2025 American Society of Clinical Oncology (ASCO) Annual Meeting Poster Presentation: ST-001 nanoFenretinide™ Trial in Patients with T-cell Non-Hodgkin Lymphoma

2025 American Society of Clinical Oncology (ASCO) Annual Meeting Poster Presentation: ST-001 nanoFenretinide™ Trial in Patients with T-cell Non-Hodgkin Lymphoma NEWS PROVIDED BY SciTech Development 05 Jun, 2025, 09:00 ET CHICAGO, Jun. 5, 2025 — SciTech Development presented a poster at the June 2025 American Society of Clinical Oncology (ASCO) meeting in Chicago, showcasing the…